The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Acquisition strengthens Roche’s AI-powered digital pathology and precision diagnostics capabilities
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Subscribe To Our Newsletter & Stay Updated
